1. Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
   Stephanie Wong et al, 2017, World Journal of Hepatology CrossRef
2. The non-invasive serum biomarkers contributes to indicate liver fibrosis staging and evaluate the progress of chronic hepatitis B
   Shaoxiong Zeng et al, 2024, BMC Infectious Diseases CrossRef
3. A New Assessment of Two Transferase-Based Liver Enzymes in Low- and High-Fibrosis Patients Chronically Infected with Hepatitis B Virus: A Meta-Analysis and Pilot Study
   Marina Manea et al, 2024, Journal of Clinical Medicine CrossRef